Modified model for predicting early C-reactive protein levels after gastrointestinal surgery: A prospective cohort study
Yui Kawasaki(Daiichi Sankyo (United States)), Munetaka Hirose(Hyogo Medical University), Soonhee Park(Hyogo Medical University), Ryusuke Ueki(Hyogo Medical University), Nobutaka Kariya(Hyogo University), Kazunori Miyamoto(Tokushima University), Tsuneo Tatara(Hyogo University)
Cited by 7
Related Papers
First-in-Human, Phase I Dose-Escalation and Dose-Expansion Study of Trophoblast Cell-Surface Antigen 2–Directed Antibody-Drug Conjugate Datopotamab Deruxtecan in Non–Small-Cell Lung Cancer: TROPION-PanTumor01
|Journal of Clinical Oncology|2023|168
Datopotamab Deruxtecan in Advanced or Metastatic HR+/HER2– and Triple-Negative Breast Cancer: Results From the Phase I TROPION-PanTumor01 Study
|Journal of Clinical Oncology|2024|158
Validation of the Pentax-AWS Airwayscope utility as an intubation device during cardiopulmonary resuscitation on the ground
|Journal of Anesthesia|2010|49